Smith Thornton Advisors
AMGN icon

Smith Thornton Advisors’s Amgen AMGN Stock Holding History

Smith Thornton Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$454K Sell
1,076
-4
-0.4% -$1.59K 0.2% 93
2026
Q2 		$389K Sell
1,080
-82
-7% -$28.1K 0.17% 101
2026
Q1 		$409K Sell
1,162
-11
-0.9% -$3.92K 0.21% 99
2025
Q4 		$384K Buy
1,173
+46
+4% +$14.6K 0.2% 102
2025
Q3 		$318K Sell
1,127
-145
-11% -$42.1K 0.17% 110
2025
Q2 		$355K Buy
1,272
+25
+2% +$7.08K 0.2% 102
2025
Q1 		$389K Buy
1,247
+62
+5% +$18.3K 0.24% 89
2024
Q4 		$309K Buy
1,185
+412
+53% +$122K 0.2% 111
2024
Q3 		$249K Hold
773
– – 0.16% 119
2024
Q2 		$242K Buy
+773
New +$227K 0.18% 114

Other funds holding AMGN

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $824B AUM 37.44% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $704B AUM 26.74% 1-Year Est. Return

Smith Thornton Advisors's AMGN Position: Q3 2026 in Review

Smith Thornton Advisors reduced its Amgen (AMGN) stake by 0.37% in Q3 2026, selling an estimated $1.59K and leaving 1,076 shares worth $454K. The position accounts for 0.2% of the portfolio, ranked #93.

Smith Thornton Advisors first reported a position in AMGN in Q2 2024 and has held it in 10 quarters since. 2,911 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Smith Thornton Advisors held 1,076 shares of Amgen worth $454K as of Q3 2026.
  • Smith Thornton Advisors sold 4 Amgen shares in Q3 2026, an estimated $1.59K.
  • Amgen made up 0.2% of Smith Thornton Advisors's portfolio in Q3 2026, its #93 holding.
  • Smith Thornton Advisors first reported a position in Amgen in Q2 2024 and has held it in 10 quarters since.
  • 2,911 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Smith Thornton Advisors's 13F filing for Q3 2026, filed 16 Oct 2026.